This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, J. A. Articles by Billestrup, N. Search for Related Content PubMed PubMed Citation Articles by Hansen, J. A. Articles by Billestrup, N.

Mechanism of Inhibition of Growth Hormone Receptor Signaling by Suppressor of Cytokine Signaling Proteins

Hagedorn Research Institute (J.A.H., K.L., J.H.N., N.B.) DK-2820 Gentofte, Denmark
The Walter and Eliza Hall Institute for Medical Research (D.J.H.) Parkville, Victoria 3052, Australia

In this study we have investigated the role of suppressor of cytokine signaling (SOCS) proteins in GH receptor-mediated signaling. GH-induced transcription was inhibited by SOCS-1 and SOCS-3, while SOCS-2 and cytokine inducible SH2-containing protein (CIS) had no effect. By using chimeric SOCS proteins it was found that the ability of SOCS proteins to inhibit GH-mediated transcription was located in the amino-terminal 40–80 amino acids. In SOCS-3, 46 amino acids C-terminal to the SH2 domain were required for the inhibitory activity, while a truncated SOCS-1 having only 2 amino acids C-terminal to the SH2 domain was able to inhibit GH-mediated transcription. Both SOCS-1 and SOCS-3 were able to inhibit GH-induced STAT5 (signal transducer and activator of transcription) activation. SOCS-1 inhibited the tyrosine kinase activity of Janus kinase 2 (JAK2) directly, while SOCS-3 only inhibited JAK2 when stimulated by the GH receptor. All four SOCS proteins were able to bind to a tyrosine-phosphorylated glutathione-S-transferase-GH receptor fusion protein, and SOCS-3 required the same 46 C-terminal amino acids for GH receptor binding as it did for inhibition of GH-mediated transcription and STAT5 activation. These data suggest that SOCS-1 and -3 can suppress GH-induced transcriptional activity, presumably by inhibiting the kinase activity of JAK2 either directly in the case of SOCS-1 or via binding to the tyrosine-phosphorylated GH receptor in the case of SOCS-3.

This article has been cited by other articles:

				G. Kenth, J. A M. Mergelas, and C. G. Goodyer Developmental changes in the human GH receptor and its signal transduction pathways J. Endocrinol., July 1, 2008; 198(1): 71 - 82. [Abstract] [Full Text] [PDF]

				T. A. Ahmed, M. D. Buzzelli, C. H. Lang, J. B. Capen, M. L. Shumate, M. Navaratnarajah, M. Nagarajan, and R. N. Cooney Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1793 - G1803. [Abstract] [Full Text] [PDF]

				J. Piessevaux, D. Lavens, T. Montoye, J. Wauman, D. Catteeuw, J. Vandekerckhove, D. Belsham, F. Peelman, and J. Tavernier Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling J. Biol. Chem., November 3, 2006; 281(44): 32953 - 32966. [Abstract] [Full Text] [PDF]

				H. Frobose, S. Groth Ronn, P. E. Heding, H. Mendoza, P. Cohen, T. Mandrup-Poulsen, and N. Billestrup Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6/TAK1 Complex Mol. Endocrinol., July 1, 2006; 20(7): 1587 - 1596. [Abstract] [Full Text] [PDF]

				T. Ahmed, G. Yumet, M. Shumate, C. H. Lang, P. Rotwein, and R. N. Cooney Tumor necrosis factor inhibits growth hormone-mediated gene expression in hepatocytes Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G35 - G44. [Abstract] [Full Text] [PDF]

				T. Buchse, H. Prietzsch, T. Sasse, S. Korbel, G. Stigge, S. Bogdanow, J. Brock, and T. Bittorf Profiling of Early Gene Expression Induced by Erythropoietin Receptor Structural Variants J. Biol. Chem., March 24, 2006; 281(12): 7697 - 7707. [Abstract] [Full Text] [PDF]

				A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista Negative Regulation of Growth Hormone Receptor Signaling Mol. Endocrinol., February 1, 2006; 20(2): 241 - 253. [Abstract] [Full Text] [PDF]

				T. Landsman and D. J. Waxman Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization J. Biol. Chem., November 11, 2005; 280(45): 37471 - 37480. [Abstract] [Full Text] [PDF]

				K Lindberg, S G Ronn, D Tornehave, H Richter, J A Hansen, J Romer, M Jackerott, and N Billestrup Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3 J. Mol. Endocrinol., October 1, 2005; 35(2): 231 - 243. [Abstract] [Full Text] [PDF]

				M. L. Shumate, G. Yumet, T. A. Ahmed, and R. N. Cooney Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G227 - G239. [Abstract] [Full Text] [PDF]

				E. Rico-Bautista, C. J. Greenhalgh, P. Tollet-Egnell, D. J. Hilton, W. S. Alexander, G. Norstedt, and A. Flores-Morales Suppressor of Cytokine Signaling-2 Deficiency Induces Molecular and Metabolic Changes that Partially Overlap with Growth Hormone-Dependent Effects Mol. Endocrinol., March 1, 2005; 19(3): 781 - 793. [Abstract] [Full Text] [PDF]

				P. Kotokorpi, C. Gardmo, C. S. Nystrom, and A. Mode Activation of the Glucocorticoid Receptor or Liver X Receptors Interferes with Growth Hormone-Induced akr1b7 Gene Expression in Rat Hepatocytes Endocrinology, December 1, 2004; 145(12): 5704 - 5713. [Abstract] [Full Text] [PDF]

				K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF]

				F. Schaefer, S.-A. Yoon, P. Nouri, T. Tsao, P. Tummala, E. Deng, and R. Rabkin Growth Hormone-Mediated Janus Associated Kinase-Signal Transducers and Activators of Transcription Signaling in the Growth Hormone-Resistant Potassium-Deficient Rat J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2299 - 2306. [Abstract] [Full Text] [PDF]

				T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF]

				J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Suppression of Growth Hormone (GH) Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 5 Signaling Pathway in Transgenic Mice Overexpressing Bovine GH Endocrinology, June 1, 2004; 145(6): 2824 - 2832. [Abstract] [Full Text] [PDF]

				J. A. Johnston Are SOCS suppressors, regulators, and degraders? J. Leukoc. Biol., May 1, 2004; 75(5): 743 - 748. [Abstract] [Full Text] [PDF]

				Y. Goldshmit, C. E. Walters, H. J. Scott, C. J. Greenhalgh, and A. M. Turnley SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation J. Biol. Chem., April 16, 2004; 279(16): 16349 - 16355. [Abstract] [Full Text] [PDF]

				P. Anderson, A. Sundstedt, L. Li, E. J. O'Neill, S. Li, D. C. Wraith, and P. Wang Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in Th1 and Th2 cells Int. Immunol., November 1, 2003; 15(11): 1309 - 1317. [Abstract] [Full Text] [PDF]

				S. W. Fox, S. J. Haque, A. C. Lovibond, and T. J. Chambers The Possible Role of TGF-{beta}-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro J. Immunol., April 1, 2003; 170(7): 3679 - 3687. [Abstract] [Full Text] [PDF]

				L. Du, G. P. Frick, L.-R. Tai, A. Yoshimura, and H. M. Goodman Interaction of the Growth Hormone Receptor with Cytokine-Induced Src Homology Domain 2 Protein in Rat Adipocytes Endocrinology, March 1, 2003; 144(3): 868 - 876. [Abstract] [Full Text] [PDF]

				F. Giordanetto and R. T. Kroemer A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1) Protein Eng. Des. Sel., February 1, 2003; 16(2): 115 - 124. [Abstract] [Full Text] [PDF]

				C. J. Greenhalgh, D. Metcalf, A. L. Thaus, J. E. Corbin, R. Uren, P. O. Morgan, L. J. Fabri, J.-G. Zhang, H. M. Martin, T. A. Willson, et al. Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling J. Biol. Chem., October 18, 2002; 277(43): 40181 - 40184. [Abstract] [Full Text] [PDF]

				S.-E. Kong, S. M. Firth, R. C. Baxter, and P. J. D. Delhanty Regulation of the acid-labile subunit in sustained endotoxemia Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E692 - E701. [Abstract] [Full Text] [PDF]

				O. Morales, M. H. Faulds, U. J. Lindgren, and L.-A. Haldosen 1alpha ,25-Dihydroxyvitamin D3 Inhibits GH-induced Expression of SOCS-3 and CIS and Prolongs Growth Hormone Signaling via the Janus Kinase (JAK2)/Signal Transducers and Activators of Transcription (STAT5) System in Osteoblast-like Cells J. Biol. Chem., September 13, 2002; 277(38): 34879 - 34884. [Abstract] [Full Text] [PDF]

				S. G. Ronn, J. A. Hansen, K. Lindberg, A. E. Karlsen, and N. Billestrup The Effect of Suppressor of Cytokine Signaling 3 on GH Signaling in {beta}-Cells Mol. Endocrinol., September 1, 2002; 16(9): 2124 - 2134. [Abstract] [Full Text] [PDF]

				G. Yumet, M. L. Shumate, P. Bryant, C.-M. Lin, C. H. Lang, and R. N. Cooney Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E472 - E481. [Abstract] [Full Text] [PDF]

				S. Ji, S. J. Frank, and J. L. Messina Growth Hormone-induced Differential Desensitization of STAT5, ERK, and Akt Phosphorylation J. Biol. Chem., August 9, 2002; 277(32): 28384 - 28393. [Abstract] [Full Text] [PDF]

				G. K. Geiss, M. Salvatore, T. M. Tumpey, V. S. Carter, X. Wang, C. F. Basler, J. K. Taubenberger, R. E. Bumgarner, P. Palese, M. G. Katze, et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza PNAS, August 6, 2002; 99(16): 10736 - 10741. [Abstract] [Full Text] [PDF]

				D. L. Krebs, R. T. Uren, D. Metcalf, S. Rakar, J.-G. Zhang, R. Starr, D. P. De Souza, K. Hanzinikolas, J. Eyles, L. M. Connolly, et al. SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation Mol. Cell. Biol., July 1, 2002; 22(13): 4567 - 4578. [Abstract] [Full Text] [PDF]

				C. M. Silva, M. T. Kloth, A. J. Whatmore, J. S. Freeth, N. Anderson, K. K. Laughlin, T. Huynh, A. J. Woodall, and P. E. Clayton GH and Epidermal Growth Factor Signaling in Normal and Laron Syndrome Fibroblasts Endocrinology, July 1, 2002; 143(7): 2610 - 2617. [Abstract] [Full Text] [PDF]

				C. J. Greenhalgh, P. Bertolino, S. L. Asa, D. Metcalf, J. E. Corbin, T. E. Adams, H. W. Davey, N. A. Nicola, D. J. Hilton, and W. S. Alexander Growth Enhancement in Suppressor of Cytokine Signaling 2 (SOCS-2)-Deficient Mice Is Dependent on Signal Transducer and Activator of Transcription 5b (STAT5b) Mol. Endocrinol., June 1, 2002; 16(6): 1394 - 1406. [Abstract] [Full Text] [PDF]

				V. Beauloye, B. Willems, V. de Coninck, S. J. Frank, M. Edery, and J.-P. Thissen Impairment of Liver GH Receptor Signaling by Fasting Endocrinology, March 1, 2002; 143(3): 792 - 800. [Abstract] [Full Text] [PDF]

				L. Gonzalez, J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn Cytokine-Inducible SH2 Protein Up-Regulation Is Associated with Desensitization of GH Signaling in GHRH-Transgenic Mice Endocrinology, February 1, 2002; 143(2): 386 - 394. [Abstract] [Full Text] [PDF]

				S.-H. Park, H. Yamashita, H. Rui, and D. J. Waxman Serine Phosphorylation of GH-Activated Signal Transducer and Activator of Transcription 5a (STAT5a) and STAT5b: Impact on STAT5 Transcriptional Activity Mol. Endocrinol., December 1, 2001; 15(12): 2157 - 2171. [Abstract] [Full Text] [PDF]

				F. Dif, E. Saunier, B. Demeneix, P. A. Kelly, and M. Edery Cytokine-Inducible SH2-Containing Protein Suppresses PRL Signaling by Binding the PRL Receptor Endocrinology, December 1, 2001; 142(12): 5286 - 5293. [Abstract] [Full Text] [PDF]

				S.-H. Park and D. J. Waxman Inhibitory Cross-talk between STAT5b and Liver Nuclear Factor HNF3beta . IMPACT ON THE REGULATION OF GROWTH HORMONE PULSE-STIMULATED, MALE-SPECIFIC LIVER CYTOCHROME P-450 GENE EXPRESSION J. Biol. Chem., November 9, 2001; 276(46): 43031 - 43039. [Abstract] [Full Text] [PDF]

				G. S. Tannenbaum, H. K. Choi, W. Gurd, and D. J. Waxman Temporal Relationship Between the Sexually Dimorphic Spontaneous GH Secretory Profiles and Hepatic STAT5 Activity Endocrinology, November 1, 2001; 142(11): 4599 - 4606. [Abstract] [Full Text] [PDF]

				S. P. Tam, P. Lau, J. Djiane, D. J. Hilton, and M. J. Waters Tissue-Specific Induction of SOCS Gene Expression by PRL Endocrinology, November 1, 2001; 142(11): 5015 - 5026. [Abstract] [Full Text] [PDF]

				A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, September 26, 2001; (2001) 211445998. [Abstract] [Full Text] [PDF]

				C. J. Greenhalgh and D. J. Hilton Negative regulation of cytokine signaling J. Leukoc. Biol., September 1, 2001; 70(3): 348 - 356. [Abstract] [Full Text] [PDF]

				A. Flores-Morales, L. Fernandez, E. Rico-Bautista, A. Umana, C. Negrin, J.-G. Zhang, and G. Norstedt Endoplasmic Reticulum Stress Prolongs GH-Induced Janus Kinase (JAK2)/Signal Transducer and Activator of Transcription (STAT5) Signaling Pathway Mol. Endocrinol., September 1, 2001; 15(9): 1471 - 1483. [Abstract] [Full Text] [PDF]

				D. L. Krebs and D. J. Hilton SOCS Proteins: Negative Regulators of Cytokine Signaling Stem Cells, September 1, 2001; 19(5): 378 - 387. [Abstract] [Full Text] [PDF]

				A. W. Roberts, L. Robb, S. Rakar, L. Hartley, L. Cluse, N. A. Nicola, D. Metcalf, D. J. Hilton, and W. S. Alexander Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3 PNAS, July 31, 2001; 98(16): 9324 - 9329. [Abstract] [Full Text] [PDF]

				B. N. Friedrichsen, E. D. Galsgaard, J. H. Nielsen, and A. Møldrup Growth Hormone- and Prolactin-Induced Proliferation of Insulinoma Cells, INS-1, Depends on Activation of STAT5 (Signal Transducer and Activator of Transcription 5) Mol. Endocrinol., January 1, 2001; 15(1): 136 - 148. [Abstract] [Full Text]

				A. Colson, A. Le Cam, D. Maiter, M. Edery, and J.-P. Thissen Potentiation of Growth Hormone-Induced Liver Suppressors of Cytokine Signaling Messenger Ribonucleic Acid by Cytokines Endocrinology, October 1, 2000; 141(10): 3687 - 3695. [Abstract] [Full Text] [PDF]

				E. LeBel, L. Vallieres, and S. Rivest Selective Involvement of Interleukin-6 in the Transcriptional Activation of the Suppressor of Cytokine Signaling-3 in the Brain during Systemic Immune Challenges Endocrinology, October 1, 2000; 141(10): 3749 - 3763. [Abstract] [Full Text] [PDF]

				M. R. Stofega, J. Herrington, N. Billestrup, and C. Carter-Su Mutation of the SHP-2 Binding Site in Growth Hormone (GH) Receptor Prolongs GH-Promoted Tyrosyl Phosphorylation of GH Receptor, JAK2, and STAT5B Mol. Endocrinol., September 1, 2000; 14(9): 1338 - 1350. [Abstract] [Full Text]

				D. DUVAL, B. REINHARDT, C. KEDINGER, and H. BOEUF Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival FASEB J, August 1, 2000; 14(11): 1577 - 1584. [Abstract] [Full Text]

				B. Emanuelli, P. Peraldi, C. Filloux, D. Sawka-Verhelle, D. Hilton, and E. Van Obberghen SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling J. Biol. Chem., May 19, 2000; 275(21): 15985 - 15991. [Abstract] [Full Text] [PDF]

				D. Krebs and D. Hilton SOCS: physiological suppressors of cytokine signaling J. Cell Sci., January 8, 2000; 113(16): 2813 - 2819. [Abstract] [PDF]

				A. Sasaki, H. Yasukawa, T. Shouda, T. Kitamura, I. Dikic, and A. Yoshimura CIS3/SOCS-3 Suppresses Erythropoietin (EPO) Signaling by Binding the EPO Receptor and JAK2 J. Biol. Chem., September 15, 2000; 275(38): 29338 - 29347. [Abstract] [Full Text] [PDF]

				P. A. Ram and D. J. Waxman Role of the Cytokine-inducible SH2 Protein CIS in Desensitization of STAT5b Signaling by Continuous Growth Hormone J. Biol. Chem., December 8, 2000; 275(50): 39487 - 39496. [Abstract] [Full Text] [PDF]

				T. J. Pircher, J. N. Geiger, D. Zhang, C. P. Miller, P. Gaines, and D. M. Wojchowski Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-Kit J. Biol. Chem., March 16, 2001; 276(12): 8995 - 9002. [Abstract] [Full Text] [PDF]

				C. Bjorbak, H. J. Lavery, S. H. Bates, R. K. Olson, S. M. Davis, J. S. Flier, and M. G. Myers Jr. SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985 J. Biol. Chem., December 15, 2000; 275(51): 40649 - 40657. [Abstract] [Full Text] [PDF]

				R. A. Mooney, J. Senn, S. Cameron, N. Inamdar, L. M. Boivin, Y. Shang, and R. W. Furlanetto Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor. A POTENTIAL MECHANISM FOR CYTOKINE-MEDIATED INSULIN RESISTANCE J. Biol. Chem., July 6, 2001; 276(28): 25889 - 25893. [Abstract] [Full Text] [PDF]

				D. Metcalf, S. Mifsud, L. Di Rago, N. A. Nicola, D. J. Hilton, and W. S. Alexander Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1) PNAS, January 22, 2002; 99(2): 943 - 948. [Abstract] [Full Text] [PDF]

				S. E. Nicholson, D. De Souza, L. J. Fabri, J. Corbin, T. A. Willson, J.-G. Zhang, A. Silva, M. Asimakis, A. Farley, A. D. Nash, et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 PNAS, June 6, 2000; 97(12): 6493 - 6498. [Abstract] [Full Text] [PDF]

				A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, October 9, 2001; 98(21): 12191 - 12196. [Abstract] [Full Text] [PDF]